Affiliation:
1. A. S. Loginov Moscow Clinical Scientific Center
2. A. S. Loginov Moscow Clinical Scientific Center; V. A. Nasonova Research Institute of Rheumatology
Abstract
Drug-induced lupus syndrome (DLS) is a rare adverse event with a variety of drugs. More than a hundred of drugs are known that can cause the development of DLS, and this list is growing as new drugs appear. Physicians of any specialty can face such complications of therapy and should be aware of this pathology. The article presents an analysis of a clinical case of DLS development against the background of long-term administration of sulfasalazine in a patient with a reliable diagnosis of rheumatoid arthritis, as well as a literature review, which includes data on the prevalence, drug groups, clinical manifestations, diagnosis and treatment of this pathology.
Subject
Materials Chemistry,Economics and Econometrics,Media Technology,Forestry
Reference9 articles.
1. Klyukvina NG, Gunchikova VM, Novikova AM. Drug-induced lupus. Sovremennaya Revmatologiya = Modern Rheumatology. 2018; 12 (4): 32–41. https://doi. org/10.14412/1996–7012–2018–4–32–41
2. Augusto Vaglio, Peter C. Grayson, Paride Fenaroli, Davide Gianfreda, Valeria Boccaletti, Gian Marco Ghiggeri, Gabriella Moroni, Drug-induced lupus: Traditional and new concepts. Autrev (2018), DOI: 10.1016/j.autrev.2018.03.016.
3. Solhjoo M, Bansal P, Goyal A, Chauhan K. Drug-Induced Lupus Erythematosus. 2021 Jan 27. In: StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2021 Jan. PMID: 28722919.
4. Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann NY Acad Sci. 2007 Jun; 1108: 166–82. DOI: 10.1196/annals.1422.019. PMID: 17893983.
5. Harnett DT, Chandra-Sekhar HB, Hamilton SF. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review. Can J Cardiol. 2014 Feb; 30 (2): 247. e11–2. DOI: 10.1016/j.cjca.2013.11.011. Epub 2013 Nov 16. PMID: 24373757.